IL129647A - -4 (-6 Fluoro (-1H) indole - 3 il) - 6,3,2,1 tetrahydro pyridines are converted, their preparation and pharmaceutical preparations containing them for the treatment of disorders of the central nervous system - Google Patents
-4 (-6 Fluoro (-1H) indole - 3 il) - 6,3,2,1 tetrahydro pyridines are converted, their preparation and pharmaceutical preparations containing them for the treatment of disorders of the central nervous systemInfo
- Publication number
- IL129647A IL129647A IL12964798A IL12964798A IL129647A IL 129647 A IL129647 A IL 129647A IL 12964798 A IL12964798 A IL 12964798A IL 12964798 A IL12964798 A IL 12964798A IL 129647 A IL129647 A IL 129647A
- Authority
- IL
- Israel
- Prior art keywords
- fluoro
- hydrogen
- indol
- compound
- compound according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9700895.7A GB9700895D0 (en) | 1997-01-17 | 1997-01-17 | Pharmaceutical compounds |
| PCT/GB1998/000113 WO1998031686A1 (en) | 1997-01-17 | 1998-01-14 | Substituted 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of cns-disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL129647A0 IL129647A0 (en) | 2000-02-29 |
| IL129647A true IL129647A (en) | 2002-02-10 |
Family
ID=10806121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12964798A IL129647A (en) | 1997-01-17 | 1998-01-14 | -4 (-6 Fluoro (-1H) indole - 3 il) - 6,3,2,1 tetrahydro pyridines are converted, their preparation and pharmaceutical preparations containing them for the treatment of disorders of the central nervous system |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20010053783A1 (es) |
| EP (1) | EP0854146B1 (es) |
| JP (1) | JPH10204090A (es) |
| KR (1) | KR20000070221A (es) |
| AR (1) | AR011422A1 (es) |
| AT (1) | ATE190617T1 (es) |
| AU (1) | AU5569298A (es) |
| CA (1) | CA2227132A1 (es) |
| CZ (1) | CZ290318B6 (es) |
| DE (1) | DE69800092T2 (es) |
| DK (1) | DK0854146T3 (es) |
| EA (1) | EA001469B1 (es) |
| ES (1) | ES2144888T3 (es) |
| GB (1) | GB9700895D0 (es) |
| GR (1) | GR3033316T3 (es) |
| HU (1) | HUP0000854A3 (es) |
| ID (1) | ID21920A (es) |
| IL (1) | IL129647A (es) |
| NO (1) | NO993372D0 (es) |
| NZ (1) | NZ335493A (es) |
| PE (1) | PE99399A1 (es) |
| PL (1) | PL334569A1 (es) |
| PT (1) | PT854146E (es) |
| SI (1) | SI0854146T1 (es) |
| SV (1) | SV1998000088A (es) |
| TR (1) | TR199901583T2 (es) |
| TW (1) | TW396156B (es) |
| WO (1) | WO1998031686A1 (es) |
| ZA (1) | ZA98300B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999010346A1 (en) * | 1997-08-22 | 1999-03-04 | Eli Lilly And Company Limited | Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands |
| GB9825413D0 (en) * | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
| GB9903784D0 (en) * | 1999-02-18 | 1999-04-14 | Lilly Co Eli | Pharmaceutical compounds |
| AR028945A1 (es) * | 2000-06-19 | 2003-05-28 | Lundbeck & Co As H | Derivados de indol |
| KR101165996B1 (ko) | 2010-04-23 | 2012-07-18 | 주식회사 녹십자 | 프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물 |
| CN105949190B (zh) * | 2016-07-04 | 2018-06-29 | 烟台凯博医药科技有限公司 | 一种制备1，8-萘啶及衍生物的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2662696A2 (fr) * | 1989-12-13 | 1991-12-06 | Rhone Poulenc Sante | Antagonistes de la serotonine, leur preparation et medicaments les contenant. |
| DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
| FR2675801A1 (fr) * | 1991-04-24 | 1992-10-30 | Rhone Poulenc Rorer Sa | Piperidines, leur preparation et les medicaments les contenant. |
| DE19500689A1 (de) * | 1995-01-12 | 1996-07-18 | Merck Patent Gmbh | Indolpiperidin-Derivate |
| US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
-
1997
- 1997-01-17 GB GBGB9700895.7A patent/GB9700895D0/en active Pending
-
1998
- 1998-01-13 TW TW087100373A patent/TW396156B/zh not_active IP Right Cessation
- 1998-01-13 US US09/005,995 patent/US20010053783A1/en not_active Abandoned
- 1998-01-14 ES ES98300249T patent/ES2144888T3/es not_active Expired - Lifetime
- 1998-01-14 EP EP98300249A patent/EP0854146B1/en not_active Expired - Lifetime
- 1998-01-14 JP JP10005897A patent/JPH10204090A/ja active Pending
- 1998-01-14 SI SI9830009T patent/SI0854146T1/xx unknown
- 1998-01-14 NZ NZ335493A patent/NZ335493A/xx unknown
- 1998-01-14 EA EA199900667A patent/EA001469B1/ru not_active IP Right Cessation
- 1998-01-14 PL PL98334569A patent/PL334569A1/xx unknown
- 1998-01-14 AT AT98300249T patent/ATE190617T1/de not_active IP Right Cessation
- 1998-01-14 CZ CZ19991510A patent/CZ290318B6/cs not_active IP Right Cessation
- 1998-01-14 HU HU0000854A patent/HUP0000854A3/hu unknown
- 1998-01-14 PT PT98300249T patent/PT854146E/pt unknown
- 1998-01-14 WO PCT/GB1998/000113 patent/WO1998031686A1/en not_active Application Discontinuation
- 1998-01-14 KR KR1019997006447A patent/KR20000070221A/ko not_active Application Discontinuation
- 1998-01-14 TR TR1999/01583T patent/TR199901583T2/xx unknown
- 1998-01-14 IL IL12964798A patent/IL129647A/en not_active IP Right Cessation
- 1998-01-14 ID IDW990623A patent/ID21920A/id unknown
- 1998-01-14 DK DK98300249T patent/DK0854146T3/da active
- 1998-01-14 DE DE69800092T patent/DE69800092T2/de not_active Expired - Fee Related
- 1998-01-14 ZA ZA98300A patent/ZA98300B/xx unknown
- 1998-01-14 AU AU55692/98A patent/AU5569298A/en not_active Abandoned
- 1998-01-15 CA CA002227132A patent/CA2227132A1/en not_active Abandoned
- 1998-01-16 AR ARP980100185A patent/AR011422A1/es unknown
- 1998-07-09 PE PE1998000607A patent/PE99399A1/es not_active Application Discontinuation
- 1998-07-16 SV SV1998000088A patent/SV1998000088A/es unknown
-
1999
- 1999-07-08 NO NO993372A patent/NO993372D0/no not_active Application Discontinuation
-
2000
- 2000-04-26 GR GR20000401000T patent/GR3033316T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0553191B1 (en) | Pyridine and pyridine n-oxide derivatives of diarylmethyl- piperidines or piperazines, compositions and use thereof | |
| US5834493A (en) | Indole derivatives as 5-HT1A and/or 5-HT2 ligands | |
| IE58122B1 (en) | An indole derivative | |
| NO335015B1 (no) | Fremgangsmåte for fremstilling av 5-HT(serotonin)-ligander | |
| US5563147A (en) | Serotonerbic tetrahydropyridoindoles | |
| CA1296730C (en) | 6,7,8,9-tetrahydropyrido[1,2-a] indole derivatives | |
| US5929072A (en) | 1H-2,1,3-benzothiadiazine-2,2-dioxide compounds or derivatives thereof | |
| EP0854146B1 (en) | Substituted 4-(6-fluoro-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders | |
| AU683700B2 (en) | Phenylindole compounds | |
| US4447434A (en) | Substituted dibenzodiazepinones | |
| NZ205786A (en) | Heterocyclic-substituted phenylindene derivatives and pharmaceutical compositions | |
| WO2000049017A1 (en) | 1-((indoly azacycloalkyl) alkyl)-2,1, 3-benzothiadiazole 2,2-dioxides exhibiting 5-ht2a receptor activity | |
| TW589312B (en) | Aryl-8-azabicyclo[3.2.1]octanes for the treatment of depression | |
| MXPA99005277A (es) | 4-(6-fluoro-(1h)-indol-3-il)-1,2,3,6-tetrahidropiridina sustituida para el tratamiento de transtornos cns | |
| CA2414115A1 (en) | Indole derivatives useful for the treatment of cns disorders | |
| EP0743946A1 (en) | 5ht2b receptor antagonists condensed indoles | |
| JPH09500912A (ja) | イミダゾ〔１，５−ａ〕インドール−３−オンのイミダゾリルアルキル誘導体およびそれらの製造法 | |
| JPH05230057A (ja) | 光学活性インダゾール―３―カルボキサミド誘導体及びそれを有効成分とする制吐剤 | |
| NZ240146A (en) | Pyridine (n-oxide) derivatives of di-aryl methyl piperidine or piperazines; |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees |